ORIC
NASDAQ
$10.42
ORIC Pharmaceuticals Inc (ORIC)
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $20.29 (+94.72%)
Market Cap
$1.15B
Free Cash Flow Yield
-9.65%
Beta (5Y)
1.45
Price Chart
Valuation
Market Cap$1.15B
P/B2.63
Profitability
EBITDA-$149M
EPS-$1.41
Financial Health
Free Cash Flow Yield-9.65%
Growth & Risk
EPS 5Y CAGR-10.25%
FCF 5Y CAGR+16.09%
Beta (5Y)1.45
Sharpe Ratio0.31